Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309898 | 0.88 | ALDH1A1 (0.31) | ALDH1A1HTTSMN1; SMN2L3MBTL1CDK19 | |
| SCHEMBL24310652 | 0.85 | KDM5B (0.30) | ALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL24310222 | 0.85 | KDM5B (0.30) | ALDH1A1HTTSMN1; SMN2L3MBTL1 | |
| SCHEMBL24309878 | 0.84 | PIK3CD (0.34) | ALDH1A1HTTPDE10A | |
| SCHEMBL24310412 | 0.82 | RORC (0.32) | — | |
| SCHEMBL24309815 | 0.82 | JAK2 (0.34) | CDK19ALK | |
| SCHEMBL24310591 | 0.78 | PDE10A (0.31) | PDE10A | |
| SCHEMBL24309723 | 0.76 | JAK2 (0.34) | CDK19ALKPDE10A | |
| SCHEMBL24309836 | 0.75 | JAK2 (0.33) | CDK19ALK | |
| SCHEMBL24309307 | 0.73 | AXL (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |